Don't want to miss the best from Business Standard?
Shasun Pharma has tanked nearly 9% to Rs 89, after the company reported 67% fall in its net profit to Rs 8.2 crore for the quarter ended December 2012. The company had posted a profit of Rs 24.6 crore during the previous corresponding quarter.
The consolidated net sales of the pharma company fell 13% to Rs 257.1 crore from Rs 295.8 crore on a year-on-year (y-o-y) basis.
The stock opened at Rs 95 on the Bombay Stock Exchange (BSE) and touched the intra-day low of Rs 86 in trades thus far. As many as 4,49,000 shares have changed hands, as compared to its two-week average of 3,12,000 shares.
Make smarter market moves with The Smart Investor. Daily insights on buzzing stocks and actionable information to guide your investment decisions delivered to your inbox.
